Tetrandrine Suppresses Activation of Human Subconjunctival Fibroblasts In Vitro

REFERENCES

• Cordeiro M F, Reichel M B, Gay J A, et al. Transforming growth factor-β 1, -β 2, and -β 3 in vivo: Effects on normal and mitomycin C-modulated conjunctival scarring. Invest Ophthalmol Vis Sci. 1999; 40: 1975–1982
   PubMed Web of Science ®Google Scholar
• Saika S, Yamanaka O, Baba Y, et al. Accumulation of latent transforming growth factor-beta binding protein-1 and TGFβ 1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmol. 2001; 239: 234–241
   PubMedGoogle Scholar
• Cordeiro M F, Bhattacharya S S, Schultz G S, et al. TGF-β 1, -β 2, and -β 3 in vitro: Biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci. 2000; 41: 756–763
   PubMed Web of Science ®Google Scholar
• Daniels J T, Schultz G S, Blalock T D, et al. Mediation of transforming growth factor-β 1 stimulated matrix contraction by fibroblasts. Am J Pathol. 2003; 163: 2043–2052
   PubMed Web of Science ®Google Scholar
• Cordeiro M F, Mead A, Ali R R, et al. Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome. Gene Ther. 2003; 10: 59–71
   PubMed Web of Science ®Google Scholar
• Elder M J, Dart J KG, Lightman S. Conjunctival fibrosis in ocular cicatricial pemphigoid-the role of cytokines. Exp Eye Res. 1997; 65: 165–176
   PubMed Web of Science ®Google Scholar
• Jampel H D, Roche N, Stark W J, et al. Transforming growth factor-β in human aqueous humor. Curr Eye Res. 1990; 9: 963–969
   PubMed Web of Science ®Google Scholar
• Khaw P T, Chang L, Wong T T, et al. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol. 2001; 12: 143–148
   PubMed Web of Science ®Google Scholar
• Siriwardena D, Khaw P T, King A J, et al. Human antitransforming growth factor β 2 monoclonal antibody—a new modulator of wound healing in trabeculectomy: A randomized placebo controlled clinical study. Ophthalmology. 2002; 109: 427–431
   PubMed Web of Science ®Google Scholar
• Nakamura H, Siddiqui S S, Shen X, et al. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol Vis. 2004; 10: 703–711
   PubMed Web of Science ®Google Scholar
• Lai J H. Immunomodulatory effects and mechanisms of plant alkaloid tetrandrine in autoimmune diseases. Acta Pharmacol Sin. 2002; 23: 1093–1101
   PubMed Web of Science ®Google Scholar
• Xie Q M, Tang H F, Chen J Q, et al. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta Pharmacol Sin. 2002; 23: 1107–1113
   PubMed Web of Science ®Google Scholar
• Wang G, Lemos J R, Iadecola C. Herbal alkaloid tetrandrine: From an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci. 2004; 25: 120–123
   PubMed Web of Science ®Google Scholar
• Reist R H, Dey R D, Durham J P, et al. Inhibition of proliferative activity of pulmonary fibroblasts by tetrandrine. Toxicol Appl Pharmacol. 1993; 122: 70–76
   PubMed Web of Science ®Google Scholar
• Lee S H, Nan J X, Sohn D H. Tetrandrine prevents tissue inhibitor of metalloproteinase-1 messenger RNA expression in rat liver fibrosis. Pharmacol Toxicol. 2001; 89: 214–216
   PubMedGoogle Scholar
• Park P H, Nan J X, Park E J, et al. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Pharmacol Toxicol. 2000; 87: 261–268
   PubMedGoogle Scholar
• Zhao Y Z, Kim J Y, Park E J, et al. Tetrandrine induces apoptosis in hepatic stellate cells. Phytother Res. 2004; 18: 306–309
   PubMedGoogle Scholar
• Fang L H, Zhang Y H, Ma J J, et al. Inhibitory effects of tetrandrine on the serum- and platelet-derived growth factor-BB-induced proliferation of rat aortic smooth muscle cells through inhibition of cell cycle progression, DNA synthesis, ERK1/2 activation and c-fos expression. Atherosclerosis. 2004; 174: 215–223
   PubMedGoogle Scholar
• Saika S, Ooshima A, Yamanaka O, et al. Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro. Graefes Arch Clin Exp Ophthalmol. 1996; 234: S214–222
   Google Scholar
• Yamanaka O, Saika S, Okada Y, et al. Effects of interferon-gamma on human subconjunctival fibroblasts in the presence of TGFβ 1: Reversal of TGFβ -stimulated collagen production. Graefes Arch Clin Exp Ophthalmol. 2003; 241: 116–124
   PubMedGoogle Scholar
• Saika S, Miyamoto T, Yamanaka O, et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-κ B, in treatment of corneal alkali burns in mice. Am J Pathol. 2005; 166: 1393–1403
   PubMed Web of Science ®Google Scholar
• Saika S, Ikeda K, Yamanaka O, et al. Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol. 2005; 166: 1405–1418
   PubMedGoogle Scholar
• Saika S, Ikeda K, Yamanaka O, et al. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest. 2004; 84: 1259–1270
   PubMedGoogle Scholar
• Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol. 2004; 164: 651–663
   PubMed Web of Science ®Google Scholar
• Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005; 13: 7–12, review
   PubMed Web of Science ®Google Scholar
• Ishida I, Saika S, Ohnishi Y. Effect of minoxidil on rabbit lens epithelial cell behavior in vitro in situ. Graefes Arch Clin Exp Ophthalmol. 2001; 239: 770–777
   PubMedGoogle Scholar
• Saika S, Ooshima A, Hashizume N, et al. Effect of lysyl hydroxylase inhibitor, minoxidil, on ultrastructure and behavior of cultured rabbit subconjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmol. 1995; 233: 347–353
   PubMedGoogle Scholar
• Hamid R, Rotshteyn Y, Rabadi L, et al. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro. 2004; 18: 703–710
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham D J. TGF-β signaling and the fibrotic response. FASEB J. 2004; 18: 816–827
   PubMed Web of Science ®Google Scholar
• Roberts A B, Piek E, Bottinger E P, et al. Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?. Chest. 2001; 720(Suppl)43S–47S
   Google Scholar
• Connor T B, Jr, Roberts A B, Sporn M B, et al. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Clin Invest. 1989; 83: 1661–1666
   PubMed Web of Science ®Google Scholar
• Picht G, Welge-Luessen U, Grehn F, et al. Transforming growth factor β 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001; 239: 199–207
   PubMed Web of Science ®Google Scholar
• Evans R A, Tian Y C, Steadman R, et al. TGF-β 1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res. 2003; 282: 90–100
   PubMed Web of Science ®Google Scholar
• Kitano A, Saika S, Yamanaka O, et al. Genipin suppresses subconjunctival fibroblast migration, proliferation and myofibroblast transdifferentiation. Ophthalmic Res. 2006; 38: 355–360
   PubMed Web of Science ®Google Scholar
• Kitano A, Saika S, Yamanaka O, et al. Emodin suppression of ocular surface inflammatory reaction. Invest Ophthalmol Vis Sci. 2007; 48: 5013–5022
   PubMed Web of Science ®Google Scholar